 |
Previous Article | Next Article 
The Journal of Neuroscience, October 15, 1998, 18(20):8145-8152
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is
Attenuated in Mice Overexpressing Bcl-2
Lichuan
Yang1, 3,
Russell T.
Matthews1, 3,
Jörg B.
Schulz4,
Thomas
Klockgether4,
Andrew
W.
Liao2,
Jean-Claude
Martinou5,
John B.
Penney Jr.3,
Bradley T.
Hyman2, and
M. Flint
Beal1, 3
1 Neurochemistry Laboratory, 2 Alzheimer's
Disease Research Laboratory, and 3 Neurology Service,
Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts 02114, 4 Experimental Neuropharmacology
Laboratory, Department of Neurology, University of Tübingen,
D-72076 Tübingen, Germany, and 5 Glaxo Institute for
Molecular Biology S.A., CH-1228 Plan-les-Ouates, Geneva,
Switzerland
The proto-oncogene Bcl-2 rescues cells from a wide variety of
insults. Recent evidence suggests that Bcl-2 protects against free
radicals and that it increases mitochondrial calcium-buffering capacity. The neurotoxicity of
1-methyl-4-phenyl-1,2,3,6-tetrahydropyride (MPTP) is thought to involve
both mitochondrial dysfunction and free radical generation. We
therefore investigated MPTP neurotoxicity in both Bcl-2 overexpressing
mice and littermate controls. MPTP-induced depletion of dopamine and
loss of [3H]mazindol binding were
significantly attenuated in Bcl-2 overexpressing mice. Protection was
more profound with an acute dosing regimen than with daily MPTP
administration over 5 d. 1-Methyl-4-phenylpyridinium (MPP+) levels after MPTP administration were similar
in Bcl-2 overexpressing mice and littermates. Bcl-2 blocked
MPP+-induced activation of caspases. MPTP-induced
increases in free 3-nitrotyrosine levels were blocked in Bcl-2
overexpressing mice. These results indicate that Bcl-2 overexpression
protects against MPTP neurotoxicity by mechanisms that may involve both
antioxidant activity and inhibition of apoptotic pathways.
Key words:
MPTP; Parkinson's disease; apoptosis; free radicals; 3-nitrotyrosine; caspases; Bcl-2
Copyright © 1998 Society for Neuroscience 0270-6474/98/18208145-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. K. Zimmermann, F. A. Loucks, E. K. Schroeder, R. J. Bouchard, K. L. Tyler, and D. A. Linseman
Glutathione Binding to the Bcl-2 Homology-3 Domain Groove: A MOLECULAR BASIS FOR BCL-2 ANTIOXIDANT FUNCTION AT MITOCHONDRIA
J. Biol. Chem.,
October 5, 2007;
282(40):
29296 - 29304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Andoh, P. B. Chock, D. L. Murphy, and C. C. Chiueh
Role of the Redox Protein Thioredoxin in Cytoprotective Mechanism Evoked by (-)-Deprenyl
Mol. Pharmacol.,
November 1, 2005;
68(5):
1408 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Shim, H.-C. Koh, M.-Y. Chang, E. Roh, C.-Y. Choi, Y. J. Oh, H. Son, Y.-S. Lee, L. Studer, and S.-H. Lee
Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL
J. Neurosci.,
January 28, 2004;
24(4):
843 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Rau, D. B. Dubal, M. Bottner, L. M. Gerhold, and P. M. Wise
Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
J. Neurosci.,
December 10, 2003;
23(36):
11420 - 11426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Crocker, P. D. Smith, V. Jackson-Lewis, W. R. Lamba, S. P. Hayley, E. Grimm, S. M. Callaghan, R. S. Slack, E. Melloni, S. Przedborski, et al.
Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease
J. Neurosci.,
May 15, 2003;
23(10):
4081 - 4091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bilsland, S. Roy, S. Xanthoudakis, D. W. Nicholson, Y. Han, E. Grimm, F. Hefti, and S. J. Harper
Caspase Inhibitors Attenuate 1-Methyl-4-Phenylpyridinium Toxicity in Primary Cultures of Mesencephalic Dopaminergic Neurons
J. Neurosci.,
April 1, 2002;
22(7):
2637 - 2649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Viswanath, Y. Wu, R. Boonplueang, S. Chen, F. F. Stevenson, F. Yantiri, L. Yang, M. F. Beal, and J. K. Andersen
Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease
J. Neurosci.,
December 15, 2001;
21(24):
9519 - 9528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vila, V. Jackson-Lewis, S. Vukosavic, R. Djaldetti, G. Liberatore, D. Offen, S. J. Korsmeyer, and S. Przedborski
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
PNAS,
February 8, 2001;
(2001)
51633998.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
O. Eberhardt, R. V. Coelln, S. Kugler, J. Lindenau, S. Rathke-Hartlieb, E. Gerhardt, S. Haid, S. Isenmann, C. Gravel, A. Srinivasan, et al.
Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
J. Neurosci.,
December 15, 2000;
20(24):
9126 - 9134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bilbao, J. L. Contreras, H.-G. Zhang, M. J. Pike, K. Overturf, G. Mikheeva, V. Krasnykh, and D. T. Curiel
Adenovirus-Mediated Gene Expression In Vivo Is Enhanced by the Antiapoptotic Bcl-2 Gene
J. Virol.,
August 1, 1999;
73(8):
6992 - 7000.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. B. Dubal, P. J. Shughrue, M. E. Wilson, I. Merchenthaler, and P. M. Wise
Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors
J. Neurosci.,
August 1, 1999;
19(15):
6385 - 6393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamada, T. Oligino, M. Mata, J. R. Goss, J. C. Glorioso, and D. J. Fink
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo
PNAS,
March 30, 1999;
96(7):
4078 - 4083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vila, V. Jackson-Lewis, S. Vukosavic, R. Djaldetti, G. Liberatore, D. Offen, S. J. Korsmeyer, and S. Przedborski
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
PNAS,
February 27, 2001;
98(5):
2837 - 2842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|